Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfister

Showing results (471-480 of 754) with videos related to

Pageof 76
Sort By:
Acta Neuropathologica|November 18, 2019
YAP1-fusions in pediatric NF2-wildtype meningiomaPhilipp Sievers, Jason Chiang, Daniel Schrimpf, et al.
Acta Neuropathologica|May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohortTorsten Pietsch, Rene Schmidt, Marc Remke, et al.
Nature Medicine|September 5, 2025
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N<sup>2</sup>M<sup>2</sup> umbrella trialWolfgang Wick, Lisa-Marie Lanz, Antje Wick, et al.
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Clinical Sarcoma Research|May 10, 2017
Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated casesChristian Koelsche, Daniel Schrimpf, Lars Tharun, et al.
Acta Neuropathologica|December 14, 2011
Biological and clinical heterogeneity of MYCN-amplified medulloblastomaAndrey Korshunov, Marc Remke, Marcel Kool, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2018
Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic informationChristian Koelsche, Wolfgang Hartmann, Daniel Schrimpf, et al.
Cell Reports|December 8, 2022
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulationMartin F Orth, Didier Surdez, Tobias Faehling, et al.
Acta Neuropathologica|April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
Neuro-Oncology|May 27, 2025
Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profilesMaximilian Y Deng, Sybren L N Maas, Günes Anil, et al.
Pageof 76

Showing results (471-480 of 754) with videos related to

Sort By:
Pageof 76
Acta Neuropathologica|November 18, 2019
YAP1-fusions in pediatric NF2-wildtype meningiomaPhilipp Sievers, Jason Chiang, Daniel Schrimpf, et al.
Acta Neuropathologica|May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohortTorsten Pietsch, Rene Schmidt, Marc Remke, et al.
Nature Medicine|September 5, 2025
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N<sup>2</sup>M<sup>2</sup> umbrella trialWolfgang Wick, Lisa-Marie Lanz, Antje Wick, et al.
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Clinical Sarcoma Research|May 10, 2017
Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated casesChristian Koelsche, Daniel Schrimpf, Lars Tharun, et al.
Acta Neuropathologica|December 14, 2011
Biological and clinical heterogeneity of MYCN-amplified medulloblastomaAndrey Korshunov, Marc Remke, Marcel Kool, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2018
Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic informationChristian Koelsche, Wolfgang Hartmann, Daniel Schrimpf, et al.
Cell Reports|December 8, 2022
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulationMartin F Orth, Didier Surdez, Tobias Faehling, et al.
Acta Neuropathologica|April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
Neuro-Oncology|May 27, 2025
Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profilesMaximilian Y Deng, Sybren L N Maas, Günes Anil, et al.
Pageof 76